Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $73.3 Million - $132 Million
-1,774,004 Reduced 90.06%
195,770 $8.27 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $38.3 Million - $50.2 Million
680,583 Added 52.79%
1,969,774 $136 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $54.4 Million - $69.8 Million
921,740 Added 250.85%
1,289,191 $95.4 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $54.3 Million - $81.6 Million
-823,485 Reduced 69.15%
367,451 $25.1 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $18.1 Million - $27.4 Million
-288,361 Reduced 19.49%
1,190,936 $112 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $14.4 Million - $21.6 Million
305,388 Added 26.01%
1,479,297 $100 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $38.2 Million - $66.8 Million
-1,257,002 Reduced 51.71%
1,173,909 $58.1 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $77.7 Million - $120 Million
2,430,911 New
2,430,911 $79 Million
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $858,201 - $1.84 Million
-24,100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $1.39 Million - $1.99 Million
24,100 New
24,100 $1.69 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $1.29 Million - $1.77 Million
-14,299 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $1.34 Million - $1.99 Million
14,299 New
14,299 $1.78 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $14.6 Million - $20.4 Million
-200,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $11.2 Million - $18.6 Million
200,200 New
200,200 $17.4 Million
Q3 2019

Nov 15, 2019

SELL
$90.37 - $122.49 $10 Million - $13.6 Million
-110,898 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $9.47 Million - $12.5 Million
105,850 Added 2096.87%
110,898 $13.1 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $5.55 Million - $8.64 Million
-89,552 Reduced 94.66%
5,048 $437,000
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $5.3 Million - $7.82 Million
94,600 New
94,600 $5.97 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $21.8 Million - $40.4 Million
-576,800 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $1.19 Million - $1.73 Million
29,994 Added 5.49%
576,800 $23.3 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $25.4 Million - $33.1 Million
546,806
546,806 $28.7 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.